Gilead (GILD) to Acquire HOOK for $10 million

By Yahoo! Finance   |   1 month ago
Gilead (GILD) to Acquire HOOK for $10 million

Gilead Sciences Inc. (NASDAQ:GILD) has invested in HOOK's antiviral programs, particularly HB-400 and HB-500. They also supported a merger between HOOK and Poolberg Pharma to strengthen their focus on immunotherapies.

Read More

Did you find this insightful?